Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer Just Canned One of Its Ozempic Killers. What's Next?
Pfizer Just Canned One of Its Ozempic Killers. What's Next?
Pfizer Just Canned One of Its Ozempic Killers. What's Next?
Submitted by
admin
on July 3, 2023 - 10:37am
Source:
Motley Fool
News Tags:
Pfizer
obesity
lotiglipron
danuglipron
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
Headline:
Pfizer Just Canned One of Its Ozempic Killers. What's Next?
snippet:
Pfizer discontinued one of its candidates to treat diabetes and obesity.
Even if it hadn't been discontinued, competing medicines would likely win out.
Don't hold your breath for the company's other candidate accomplishing much.
Do Not Allow Advertisers to Use My Personal information